Figure 5. Percentage of absence of exons 1, 2, 3 and 5 in our study population. Globally for Benin (B) and Niger (N) together [36] the loss was 17.53 % for exon 1 (Ex1); 31.34% for exon 2 (Ex2); 19.5% for exon 3 (Ex3) and 31.63 % for exon 5 (Ex5). Nos mutations was observed the control samples (Temoins)

From

The Prediagnosis of Prostate Cancer Risk is Possible with the Evaluation of BRCA1 Primary Exons in Men

Haboubacar Elhadji Yaou Moussa, Maazou Halidou, Sara Y. Houngue, Josué Avakoudjo, Solomon Oladapo Rotimi, Callinice D. Capo-Chichi

• Previous
• Figure 5 of 5  (Figures index)